A schedule of events for Leveraging Big Data II: What Does It Mean for Improving Product Development and Health Care is provided below for your convenience.
This one-day conference scheduled for Tuesday, February 11, 2014, will be held in the Southern Management Corporation Campus Center at the University of Maryland, Baltimore. It is open to the public. For a printable agenda, please Download the conference brochure.
| Time | Activity |
|---|---|
| 10:00-10:15 a.m. | Welcome and Objectives James Polli, PhD Shangraw/Noxell Endowed Chair in Industrial Pharmaceutics Co-Principal Investigator, Center for Excellence in Regulatory Science and Innovation University of Maryland School of Pharmacy Eleanor Perfetto, PhD, MS Professor of Pharmaceutical Health Services Research University of Maryland School of Pharmacy |
| 10:15-12:00 p.m. | Use of Big and Real-World Data by phrma: More than Data Warehousing Aaron Galaznik, MD Senior Director, Real-World Data and Analytics Pfizer, Inc. Leveraging Real-World Data and Analytics in the Device Industry Thomas Abbott, PhD Head, Health Care Informatics Johnson & Johnson, Medical Devices and Diagnostics Janus Clinical Trials Repository: An Update and Insights into Future Directions Lilliam Rosario, PhD Director, Office of Computational Science Food and Drug Administration (FDA) Panel Q&A Morning Session Moderator: Jennifer Graff, PharmD, Director of Comparative Effectiveness Research at the National Pharmaceutical Council |
| 12:00-12:20 p.m. | Break (Guests Receive Lunch and Return to Room for Lunch Speaker) |
| 12:20-1:15 p.m. | Introduction of Lunch Speaker James Polli, PhD Shangraw/Noxell Endowed Chair in Industrial Pharmaceutics Co-Principal Investigator, Center for Excellence in Regulatory Science and Innovation University of Maryland School of Pharmacy IMEDS: Sentinel and OMOP Programs Jane Reese-Coulbourne, MS, ChE Executive Director Reagan-Udall Foundation, FDA |
| 1:15-2:50 p.m. | Big Data and the "Research Harbor" Concept Kate Tracy, PhD Associate Professor of Epidemiology and Public Health University of Maryland School of Medicine Big Data and Data Visualization: Extracting Insights from Electronic Health Records Ben Shneiderman, PhD Director, Human Computer Interaction Lab University of Maryland, College Park FDA Use of Big Data in Modeling and Simulations Jeffry Florian, PhD Review, Division of Pharmacometrics Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research, FDA Panel Q&A Afternoon Session Moderator: TBD |
| 2:50-3:50 p.m. | Invited Reactor Panel with Representatives from the National Pharmaceutical Council (Jennifer Graff), Optum Labs (William Crown), Patient-Centered Outcomes Research Institute (Sarah Daugherty), and FDA (Taha Kass-Hout) Reactor Panel Moderator: Eleanor Perfetto, PhD, MS, Professor of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy |
| 3:50-4:00 p.m. | Closing Remarks James Polli, PhD Shangraw/Noxell Endowed Chair in Industrial Pharmaceutics Co-Principal Investigator, Center for Excellence in Regulatory Science and Innovation University of Maryland School of Pharmacy Eleanor Perfetto, PhD, MS Professor of Pharmaceutical Health Services Research University of Maryland School of Pharmacy |